The U.S. Food and Drug Administration is notifying health care professionals and patients that Tyco Healthcare Group LP (Covidien) is recalling one lot of ReliOn sterile, single-use, disposable, ...
ROCKVILLE, Md. Food and Drug Administration said Wednesday that Tyco Healthcare Group is recalling a lot of its ReliOn single-use syringes for diabetics. The recall affects lot number 813900, which ...
People with diabetes who use ReliOn insulin syringes should check their syringe package because of an important recall. Tyco Healthcare Group (Covidien) is recalling 4,710 boxes of the syringes - with ...
The U.S. Food and Drug Administration is notifying health care professionals and patients that Tyco Healthcare Group LP (Covidien) is recalling one lot of ReliOn sterile, single-use, disposable, ...
Nearly half a million syringes for diabetics have been recalled by their manufacturer because of possible mislabeling that could lead to insulin overdoses. Wire services are reporting that the ...
The FDA announced that Covidien, formerly Tyco Healthcare, recalled one lot of Relion sterile, single-use, disposable, hypodermic syringes with affixed hypodermic needles due to possible mislabeling.
Law360 (November 6, 2008, 12:00 AM EST) -- A Massachusetts-based health care firm and the U.S. Food and Drug Administration issued a nationwide recall on Thursday for ...
People with diabetes who use ReliOn insulin syringes should check their syringe package because of an important recall. Tyco Healthcare Group (Covidien) is recalling 4,710 boxes of the syringes -- ...
Covidien is voluntarily recalling a single lot of ReliOn insulin syringes due to possible mislabeling. During the packaging process some U-40 syringes were mixed with syringes labeled for use with ...
WASHINGTON, Nov. 6 (UPI) -- The U.S. Food and Drug Administration announced the recall of some ReliOn-brand single-use, disposable hypodermic syringes due to a potential health hazard. The FDA said ...
Covidien Ltd. is recalling 471,000 disposable insulin syringes because of mislabeling that could cause patients to receive an overdose, federal regulators said. The company’s ReliOn hypodermic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results